7.3415  -1.229 (-14.33%)		08-18 10:59
Open: 7.8 High: 7.9463 Volume: 13,679		Pre. Close: 8.57 Low: 7.176 Market Cap: 5(M)

Short term
Mid term
Targets	6-month :	9.91	1-year :	11.31
Resists	First :	8.48	Second :	9.68
Pivot price	7.2
Supports	First :	6.53	Second :	5.44
MAs	MA(5) :	7.5	MA(20) :	7.22
	MA(100) :	7.73	MA(250) :	9.36
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	56.9	D(3) :	54.4
RSI	RSI(14): 51.4
52-week	High :	38.54	Low :	3.07

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MLEC ] has closed below upper band by 33.2%. Bollinger Bands are 46.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 60 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	9.13 - 9.17	9.17 - 9.19
Low:	6.64 - 6.67	6.67 - 6.7
Close:	8.51 - 8.57	8.57 - 8.62

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Sat, 15 Aug 2026
Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits

Thu, 13 Aug 2026
Moolec Science SA (MLEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Mon, 27 Jul 2026
Moolec Science SA Revenue Breakdown – NASDAQ:MLEC - TradingView

Thu, 14 May 2026
Moolec Science (MLEC) Earnings Date and Reports 2026 - MarketBeat

Tue, 07 Apr 2026
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds - ACCESS Newswire

Mon, 06 Apr 2026
MLEC’s Insider News Sends Ripples Through the Market - timothysykes.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	1 (M)
Shares Float	0 (M)
Held by Insiders	21 (%)
Held by Institutions	2.2 (%)
Shares Short	9 (K)
Shares Short P.Month	21 (K)

EPS	-199.03
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.69
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.04
PEG Ratio	0
Price to Book value	10.68
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.